Levine Cancer Institute-Rock Hill — Rock Hill, South Carolina

Levine Cancer Institute-Rock Hill is a clinical research site located in Rock Hill, South Carolina, United States 29732.

Crixeo Clinical Trials Trust Score: 26/100 (FAILING). This profile has not yet been claimed by the site owner.

Levine Cancer Institute-Rock Hill has participated in 42 clinical trials with 31 currently active.

Therapeutic areas: Pancreatic Adenocarcinoma, Borderline Resectable Adenocarcinoma of the Head of the Pancrease, Breast Cancer.

Sponsors: Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network, Canadian Cancer Trials Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rock Hill

Browse all research sites in South Carolina · View every site in Rock Hill

Sponsor Feasibility Report

Trust Score: 26/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Levine Cancer Institute-Rock Hill?

Levine Cancer Institute-Rock Hill has a Crixeo Trust Score of 26/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Levine Cancer Institute-Rock Hill conducted?

Levine Cancer Institute-Rock Hill has 42 clinical trials on record, with 31 currently active. Their work covers Pancreatic Adenocarcinoma, Borderline Resectable Adenocarcinoma of the Head of the Pancrease, Breast Cancer.

Is Levine Cancer Institute-Rock Hill accredited by Crixeo Clinical Trials?

Levine Cancer Institute-Rock Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Levine Cancer Institute-Rock Hill?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.